Net sales by business area
| 2023 | 2022 | |||||||
|---|---|---|---|---|---|---|---|---|
| Quarterly data, SEKm | Q3 | Q2 | Q1 | Q4 | Q3 | Q2 | Q1 | |
| Labtech | 827 | 872 | 905 | 958 | 856 | 786 | 1,280 | |
| Medtech | 1,494 | 1,496 | 1,554 | 1,367 | 1,246 | 1,296 | 1,301 | |
| Group items | -2 | -3 | -2 | 1 | -2 | -3 | -2 | |
| AddLife Group | 2,319 | 2,365 | 2,457 | 2,326 | 2,100 | 2,079 | 2,579 | |
EBITA by business area
| 2023 | 2022 | |||||||
|---|---|---|---|---|---|---|---|---|
| Quarterly data, SEKm | Q3 | Q2 | Q1 | Q4 | Q3 | Q2 | Q1 | |
| Labtech | 99 | 107 | 115 | 138 | 116 | 117 | 296 | |
| Medtech | 150 | 145 | 256 | 121 | 179 | 129 | 144 | |
| Parent Company and Group items | -5 | -5 | -5 | -1 | -7 | -6 | -5 | |
| EBITA | 244 | 247 | 366 | 258 | 288 | 240 | 435 | |
| Depreciation intangible assets | -112 | -111 | -108 | -109 | -105 | -102 | -97 | |
| Operating profit | 132 | 136 | 258 | 149 | 183 | 138 | 338 | |
| Finance income and expenses | -71 | -66 | -52 | -72 | -41 | -44 | -49 | |
| Profit after financial items | 61 | 70 | 206 | 77 | 142 | 94 | 289 | |
Latest updated: 8/21/2023 10:45:40 AM by Alexander Paziraei